Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Dominant Epstein-Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment.
Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences.
Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt".
Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.
Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.
AAAS joins the Translational Medicine family.
Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.
Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation.
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins.